Data Integrity & Digital Pharma Operations – Page 25

Manual result override risks in LIMS result entry and review: Data Integrity Risks and Corrective Controls

Identifying symptoms of LIMS data integrity issues is crucial for timely intervention. Common signals that suggest potential problems related to manual overrides in result entry and review include:Click to read…

How to Prevent CDS Report Template Control in CDS (Chromatography Data System) Risks

Identifying CDS data integrity risks begins with recognizing the telltale signs that indicate potential issues. Symptoms may include:Click to read the full article.

Data Integrity During Inspections: Red Flags in Paper Logbooks

Identifying symptoms associated with compromised data integrity in paper logbooks is crucial for early intervention. Frequent symptoms include:Click to read the full article.

Missing chain-of-custody links in LIMS specification management: Data Integrity Risks and Corrective Controls

During a routine internal audit, the Quality Control (QC) team discovered discrepancies related to the chain-of-custody documentation for samples managed within the LIMS. Alarmingly, several samples lacked recorded transfers in…

Instrument Interface Failures: Root Causes, GMP Risks, and CAPA Controls

Identifying symptoms of instrument interface failures is the first crucial step toward resolution. Common indicators include:Click to read the full article.

How to Prepare Electronic Batch Records for Data Integrity Review

Being able to recognize early symptoms that suggest potential data integrity issues is the first step towards resolving them effectively. The following are common signals to watch for:Click to read…

Audit trail review gaps in LIMS specification management: Data Integrity Risks and Corrective Controls

During a routine internal audit, discrepancies were identified in the audit trails related to specification management within the LIMS. Specific symptoms included:Click to read the full article.

Inspection-Ready Approach to CDS Disaster Recovery in Pharmaceutical Operations

Identifying symptoms early is crucial in containing a CDS disaster. Typical signs may include:Click to read the full article.

Inspection Readiness for Data Integrity in Contract Testing Laboratories

Ensuring Data Integrity in Contract Testing Laboratories for Inspection Readiness Data integrity issues have emerged as a significant pain point for pharmaceutical manufacturing and testing facilities, particularly in contract testing…

Why CDS Audit Trail Red Flags Happens and How QA Teams Should Control It

Identifying early signals of CDS data integrity issues is critical to preventing regulatory non-compliance and ensuring reliable outcomes. Symptoms may manifest in various forms, including:Click to read the full article.

How to Manage Inspector Requests for Deleted or Voided Records

In a recent scenario at XYZ Pharmaceuticals, a routine inspection revealed discrepancies related to the documentation of raw material usage. The inspector noted the absence of audit trails for several…

Step-by-Step Guide to Managing Chromatographic Method Transfer Risks Under ALCOA+ Expectations

Identifying signs of potential data integrity issues during chromatographic method transfers is essential. The following symptoms may indicate a problem:Click to read the full article.